Login / Signup
Therapeutic Compatibility of Orally Administered Racemic Ketamine with Modafinil, a CYP3A4 Enzyme Inducer, in Treatment-Refractory Major Depressive Disorder.
Chittaranjan Andrade
Published in:
Indian journal of psychological medicine (2023)
Keyphrases
</>
major depressive disorder
bipolar disorder
pain management
combination therapy
replacement therapy